CoChat

TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease

Open access
Zekavat, Seyedeh M., Viana-Huete, Vanesa, Matesanz, Nuria, Jorshery, Saman Doroodgar, Zuriaga, María A., Uddin, Md Mesbah, Trinder, Mark, Paruchuri, Kaavya, Zorita, Virginia, Ferrer-Pérez, Alba, Amorós-Pérez, Marta, Kunderfranco, Paolo, Carriero, Roberta, Greco, Carolina M., Aroca-Crevillen, Alejandra, Hidalgo, Andrés, Damrauer, Scott M., Ballantyne, Christie M., Niroula, Abhishek, Gibson, Christopher J., Pirruccello, James, Griffin, Gabriel, Ebert, Benjamin L., Libby, Peter, Fuster, Valentín, Zhao, Hongyu, Ghassemi, Marzyeh, Natarajan, Pradeep, Bick, Alexander G., Fuster, José J., Klarin, Derek · 2023 · Nature Cardiovascular Research
Cited by 146

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and the Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across multiple beds, with increased risk among individuals with CHIP driven by mutation in DNA damage repair (DDR) genes, such as TP53 and PPM1D. To model the effects of DDR-induced CHIP on atherosclerosis, we used a competitive bone marrow transplantation strategy and generated atherosclerosis-prone Ldlr−/− chimeric mice carrying 20% p53-deficient hematopoietic cells. The chimeric mice were analyzed 13 weeks after grafting and showed increased aortic plaque size and accumulation of macrophages within the plaque, driven by increased proliferation of p53-deficient plaque macrophages. In summary, our findings highlight the role of CHIP as a broad driver of atherosclerosis across the entire arterial system beyond the coronary arteries and provide genetic and experimental support for a direct causal contribution of TP53-mutant CHIP to atherosclerosis. Zekavat, Matesanz, Viana-Huete et al. show an increased risk of peripheral artery disease and atherosclerosis in different vascular beds in patients with clonal hematopoiesis of indeterminate potential (CHIP) caused by mutations in DNA damage repair genes, such as TP53. Validations in a mouse model support the causal contribution of TP53-mutant CHIP to atherosclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s44161-022-00206-6

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 146

Metadata

Authors
Zekavat, S. M., Viana-Huete, V., Matesanz, N., Jorshery, S. D., Zuriaga, M. A., Uddin, M. M., Trinder, M., Paruchuri, K., Zorita, V., Ferrer-Pérez, A., Amorós-Pérez, M., Kunderfranco, P., Carriero, R., Greco, C. M., Aroca-Crevillen, A., Hidalgo, A., Damrauer, S. M., Ballantyne, C. M., Niroula, A., Gibson, C. J., Pirruccello, J., Griffin, G., Ebert, B. L., Libby, P., Fuster, V., Zhao, H., Ghassemi, M., Natarajan, P., Bick, A. G., Fuster, J. J., & Klarin, D.
Venue
Nature Cardiovascular Research
Published
2023-01-16
Volume
2
Issue
2
Pages
144-158
ISSN
2731-0590 (ISSN-L)
OpenAlex
W4316506860
Cited by
146
References
17
FWCI
12.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. https://app.cochat.ai/papers/10.1038/s44161-022-00206-6
The paper
Zekavat, S. M., Viana-Huete, V., Matesanz, N., Jorshery, S. D., Zuriaga, M. A., Uddin, M. M., Trinder, M., Paruchuri, K., Zorita, V., Ferrer-Pérez, A., Amorós-Pérez, M., Kunderfranco, P., Carriero, R., Greco, C. M., Aroca-Crevillen, A., Hidalgo, A., Damrauer, S. M., Ballantyne, C. M., Niroula, A., . . . Klarin, D. (2023). TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nature Cardiovascular Research. https://doi.org/10.1038/s44161-022-00206-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.